| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 阳景 | 浦银国际证券 | 医药生物 | 43.27% | 44.56% | 22.21% | 100.00% | 3 | 0.00% | 2025-07-17 |
| 2 | 张林晚 | 上海证券 | 医药生物 | 43.19% | 43.06% | 35.36% | -100.00% | 1 | -18.93% | 2025-08-01 |
| 3 | 华挺 | 财通证券 | 医药生物 | 43.15% | 40.58% | 18.95% | -6.67% | 10 | -50.33% | 2025-08-14 |
| 4 | 彭波 | 甬兴证券 | 医药生物 | 43.15% | 38.98% | 41.24% | 20.00% | 12 | -24.57% | 2025-08-14 |
| 5 | 叶思奥 | 光大证券 | 医药生物 | 43.08% | 34.92% | 48.98% | -60.00% | 3 | -47.18% | 2025-08-15 |
| 6 | 唐寅灏 | 中信证券 | 医药生物 | 43.07% | 41.09% | 29.83% | 60.00% | 12 | -8.47% | 2025-06-25 |
| 7 | 刘浩 | 华创证券 | 医药生物 | 43.01% | 43.58% | 41.95% | 20.00% | 2 | -47.33% | 2025-04-30 |
| 8 | 顾资然 | 中信证券 | 医药生物 | 42.95% | 40.58% | 29.84% | 100.00% | 6 | 0.00% | 2025-08-08 |
| 9 | 唐寅灏 | 中信证券 | 医药生物 | 42.92% | 38.95% | 25.70% | 60.00% | 12 | -8.47% | 2025-06-18 |
| 10 | 张林晚 | 上海证券 | 医药生物 | 42.91% | 42.77% | 35.09% | -100.00% | 1 | -18.93% | 2025-07-30 |
| 11 | 夏禹 | 国联民生 | 医药生物 | 42.91% | 41.03% | 22.73% | 20.00% | 7 | -52.01% | 2025-06-20 |
| 12 | 胡博新 | 华鑫证券 | 医药生物 | 42.90% | 46.63% | 38.52% | -6.38% | 3 | -51.98% | 2025-07-22 |
| 13 | 王道 | 申万宏源 | 医药生物 | 42.90% | 44.58% | 45.71% | -11.11% | 4 | -42.73% | 2025-08-01 |
| 14 | 胡博新 | 华鑫证券 | 医药生物 | 42.89% | 47.33% | 45.92% | -6.38% | 3 | -51.98% | 2025-07-28 |
| 15 | 赵海春 | 国金证券 | 医药生物 | 42.85% | 43.55% | 53.41% | -23.08% | 2 | -61.07% | 2025-08-15 |
| 16 | 赵海春 | 国金证券 | 医药生物 | 42.84% | 49.36% | 47.76% | -23.08% | 2 | -61.07% | 2025-07-15 |
| 17 | 杨松 | 天风证券 | 医药生物 | 42.75% | 41.34% | 31.40% | -45.36% | 19 | -72.65% | 2025-08-15 |
| 18 | 彭波 | 甬兴证券 | 医药生物 | 42.73% | 40.52% | 41.73% | 20.00% | 12 | -24.57% | 2025-08-13 |
| 19 | 唐寅灏 | 中信证券 | 医药生物 | 42.71% | 40.56% | 21.66% | 60.00% | 12 | -8.47% | 2025-06-30 |
| 20 | 夏禹 | 国联民生 | 医药生物 | 42.71% | 41.01% | 20.00% | 20.00% | 7 | -52.01% | 2025-06-27 |